This segment focuses on providing comprehensive dental healthcare services through a network of approximately 32 dental hospitals. Research and development activities include the exploration of advanced dental technologies, such as digital dentistry, CAD/CAM systems, and 3D printing for prosthetics. The segment utilizes technologies like intraoral scanners, CBCT imaging, and advanced dental materials to improve diagnostic accuracy and treatment outcomes. Therapeutic areas include general dentistry, orthodontics, periodontics, endodontics, and cosmetic dentistry. The patient impact is significant, as the segment aims to improve oral health, enhance aesthetics, and restore function for a wide range of dental conditions. Market positioning is strong due to the company's established presence in China and its focus on quality dental care. Future opportunities include expanding the network of dental hospitals, integrating telemedicine for remote consultations, and offering specialized dental services. Regulatory aspects involve compliance with Chinese healthcare regulations and obtaining necessary licenses and certifications. Partnerships with dental equipment suppliers and technology providers are crucial for staying at the forefront of dental innovation.

This segment provides assisted reproductive medical services, including in-vitro fertilization (IVF) and related treatments. Research and development efforts focus on improving IVF success rates, developing advanced embryo selection techniques, and exploring innovative fertility treatments. The segment utilizes technologies such as preimplantation genetic testing (PGT), advanced sperm selection methods, and minimally invasive surgical techniques. Therapeutic areas include infertility treatment, fertility preservation, and reproductive endocrinology. The patient impact is substantial, as the segment helps couples and individuals achieve their dream of parenthood. Market positioning is competitive, with a focus on providing high-quality reproductive care and personalized treatment plans. Future opportunities include expanding the range of fertility services, incorporating artificial intelligence for improved outcomes, and exploring new technologies in reproductive medicine. Regulatory aspects involve compliance with Chinese regulations on assisted reproductive technologies and obtaining necessary permits and licenses. Partnerships with pharmaceutical companies and research institutions are essential for advancing reproductive healthcare.

This segment focuses on providing comprehensive ophthalmological services, including diagnosis, treatment, and surgical procedures for various eye conditions. Research and development activities include the exploration of advanced diagnostic tools, innovative surgical techniques, and new treatments for common eye diseases. The segment utilizes technologies such as optical coherence tomography (OCT), femtosecond lasers for refractive surgery, and advanced intraocular lenses (IOLs). Therapeutic areas include cataract surgery, refractive surgery (LASIK, SMILE), glaucoma treatment, and retinal disease management. The patient impact is significant, as the segment aims to improve vision, prevent blindness, and enhance the quality of life for patients with eye disorders. Market positioning is competitive, with a focus on providing high-quality eye care services and utilizing advanced technologies. Future opportunities include expanding the range of ophthalmological services, incorporating artificial intelligence for improved diagnostics, and exploring new treatments for age-related macular degeneration (AMD) and other retinal diseases. Regulatory aspects involve compliance with Chinese healthcare regulations and obtaining necessary licenses and certifications. Partnerships with medical device manufacturers and pharmaceutical companies are crucial for staying at the forefront of ophthalmological innovation.